Benign Breast Tumors

Study on cryoablation eradicating benign breast tumors released

Published in Women's Health Weekly, February 17th, 2005

Sanarus Inc. announced that 12-month follow-up data from a peer-reviewed, prospective multinational study demonstrated that cryoablation is an excellent minimally invasive treatment option for eradicating benign breast tumors.

The study, published in the journal The Breast, showed that 12 months after cryoablation with an improved cryoablation protocol the average volume reduction of the 68 benign tumors treated was 91%. Also, of the tumors less than 2.5 cm in diameter, 84% were not palpable at 12 months.

It is estimated that 1.4 to 1.6 million women undergo breast biopsy in the United States. Eighty percent of the biopsies result in the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2005-02-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry